Neuro II
Active substance: TARAXACUM OFFICINALE, GOLDENSEAL, ACETYLCHOLINE CHLORIDE, HISTAMINE DIHYDROCHLORIDE, EPINEPHRINE, .GAMMA.-AMINOBUTYRIC ACID, NOREPINEPHRINE BITARTRATE, TYRAMINE
LIQUID · TARAXACUM OFFICINALE 3 [hp_X]/mL, GOLDENSEAL 6 [hp_X]/mL, ACETYLCHOLINE CHLORIDE 6 [hp_X]/mL, HISTAMINE DIHYDROCHLORIDE 6 [hp_X]/mL, EPINEPHRINE 8 [hp_X]/mL, .GAMMA.-AMINOBUTYRIC ACID 8 [hp_X]/mL, NOREPINEPHRINE BITARTRATE 8 [hp_X]/mL, TYRAMINE 12 [hp_X]/mL
United StatesActive
Marketing holder: Deseret Biologicals, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- TARAXACUM OFFICINALE · 3 [hp_X]/mL
- GOLDENSEAL · 6 [hp_X]/mL
- ACETYLCHOLINE CHLORIDE · 6 [hp_X]/mL
- HISTAMINE DIHYDROCHLORIDE · 6 [hp_X]/mL
- EPINEPHRINE · 8 [hp_X]/mL
- .GAMMA.-AMINOBUTYRIC ACID · 8 [hp_X]/mL
- NOREPINEPHRINE BITARTRATE · 8 [hp_X]/mL
- TYRAMINE · 12 [hp_X]/mL
Registration
- Registration number
- 43742-1449
- Registration status
- Active
- Dispensing
- Over the counter
- Route
- ORAL
Sources
- product · openFDA NDC · 43742-1449 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 43742-1449 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 43742-1449 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 43742-1449 · Verified 2026-10-09 · open in source
- ingredients.2 · openFDA NDC · 43742-1449 · Verified 2026-10-09 · open in source
- ingredients.3 · openFDA NDC · 43742-1449 · Verified 2026-10-09 · open in source
- ingredients.4 · openFDA NDC · 43742-1449 · Verified 2026-10-09 · open in source
- ingredients.5 · openFDA NDC · 43742-1449 · Verified 2026-10-09 · open in source
- ingredients.6 · openFDA NDC · 43742-1449 · Verified 2026-10-09 · open in source
- ingredients.7 · openFDA NDC · 43742-1449 · Verified 2026-10-09 · open in source